From Upstream BIO's results release of 2026年11月10日; its quarterly report has since been filed.

• Revenue

  Actual

  US$395K

  -42% y/y ↓
  -49% q/q ↓

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  -US$0.75

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  -US$43.4M

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.